EBV-Related Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

EBV-Related Carcinoma

histology

Identifier: CI-CAN-00002570
Entity page: /cancer/ebv-related-carcinoma ↗
Edges: 12

Neighbours: 3 drugs9 trials
Drawn: 12 of 12 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
EBV-Related Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived3 of 3
→ investigated in trials for	Pembrolizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	EBV-Related Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants

EBV-Related Carcinoma studied in …STUDIED_INderived9 of 9
→ studied in	NCT04925544Phase 2 · active not recruiting Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	EBV-Related Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02065362Phase 1 · active not recruiting TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	EBV-Related Nasopharyngeal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05581550NA · completed Somatostatin Receptor Imaging in NPC, EBV Related Cancers · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	EBV-Related Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05166577Phase 1 · terminated Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC · condition mapped ONTOLOGY_EXACT · 9 trials mapped (3 active)	—	—	EBV-Related Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03769467Phase 1/Phase 2 · terminated Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	EBV-Related Nasopharyngeal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05864924Phase 1 · completed A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	EBV-Related Nasopharyngeal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05970627Phase 2 · not yet recruiting Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma · condition mapped ALIAS · 9 trials mapped (3 active)	—	—	EBV-Related Gastric Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03923842Phase 2 · unknown Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours · condition mapped ONTOLOGY_EXACT · 9 trials mapped (3 active)	—	—	EBV-Related Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03314051completed Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA · condition mapped ONTOLOGY_EXACT · 9 trials mapped (3 active)	—	—	EBV-Related Carcinoma	1	Observed	clinicaltrials	graph →